FSMAX
Price
$102.72
Change
+$1.18 (+1.16%)
Updated
Oct 8 closing price
Net Assets
41.44B
TCMGX
Price
$22.13
Change
+$0.24 (+1.10%)
Updated
Oct 8 closing price
Net Assets
787.14M
Interact to see
Advertisement

FSMAX vs TCMGX

Header iconFSMAX vs TCMGX Comparison
Open Charts FSMAX vs TCMGXBanner chart's image
Fidelity Extended Market Index
Price$102.72
Change+$1.18 (+1.16%)
VolumeN/A
Net Assets41.44B
Nuveen Quant Mid Cap Growth A
Price$22.13
Change+$0.24 (+1.10%)
VolumeN/A
Net Assets787.14M
FSMAX vs TCMGX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. TCMGX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and TCMGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. TCMGX (787M). FSMAX pays higher dividends than TCMGX: FSMAX (0.44) vs TCMGX (0.00). FSMAX was incepted earlier than TCMGX: FSMAX (14 years) vs TCMGX (23 years). TCMGX (0.85) is less costly to investors than FSMAX (0.04). TCMGX is a more actively managed with annual turnover of: 47.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than TCMGX: FSMAX (0) vs TCMGX (2500). FSMAX annual gain was more profitable for investors over the last year : 17.85 vs. TCMGX (12.95). FSMAX return over 5 years is better than : 50.18 vs. TCMGX (-14.46).
FSMAXTCMGXFSMAX / TCMGX
Total Expense Ratio0.040.854%
Annual Report Gross Expense Ratio0.040.854%
Fund Existence14 years23 years-
Gain YTD11.7307.833150%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets41.4B787M5,260%
Annual Yield % from dividends0.440.00-
Returns for 1 year17.8512.95138%
Returns for 3 years68.0044.20154%
Returns for 5 years50.18-14.46-347%
Returns for 10 years104.775.901,775%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOLV72.430.27
+0.37%
Solventum Corp
INBX33.610.11
+0.33%
Inhibrx Biosciences Inc.
INCR1.61N/A
-0.31%
Intercure Ltd
EYE27.54-0.26
-0.94%
National Vision Holdings
UGRO0.40-0.01
-3.30%
urban-gro